Service 01 / Flagship

Healthcare market maps
built to win the first call.

Ranked call lists of physician groups, enriched with decision-maker identification, transaction-readiness signals, geo maps, and approach notes. For buy-side acquirers and sell-side bankers sourcing proprietary deal flow. Practitioner-built, delivered in days.

The Problem

The pipeline that matters is the one built before a banker runs a process.

Most healthcare deal teams are running more active processes with the same team they had three years ago. PE associates are buried in live deals. Bankers are covering more sub-sectors than their analysts can track. The average firm sees 17.6% of the deal flow relevant to its strategy. The other 82% never crosses the desk.

The default fix is a data stack. PitchBook. Grata. S&P Capital IQ. ZoomInfo. Definitive Healthcare. Clay. Real line items running $50,000 to $200,000 a year across three to five platforms. The analyst is still building the list by hand - because the platforms get you to a universe of names, not a call sheet. They won’t tell you the physician owner is 63 with no succession plan, whether a junior partner recently left the group, or which 15 of 200 names are worth a call this month. Minimum two to three weeks of scrubbing and enrichment, every engagement.

The other instinct is to hire. A senior-level BD professional with real healthcare deal experience runs $250,000 to $410,000 fully loaded in Year 1. That cost sits on SG&A. At 10x to 14x EBITDA, every dollar of permanent overhead is $10 to $14 off enterprise value at exit. And most BD hires spend their first 90 days building the target list. That list should exist before they start.

The firms that source deals off-market build the map before they hire against it. No platform subscriptions. No workbooks. The finished work product - delivered in days.

What You Get

A working call sheet - not a lead list.

Delivered as an Excel workbook and executive summary PDF. Format varies by engagement - typically includes a ranked call sheet, practice profiles and approach notes, competitive landscape, market context, and methodology.

01

Ranked target universe

Fifty to two hundred targets depending on sub-sector and geography, scored against your criteria: provider count, location density, payer mix signals, succession timing, and strategic fit.

02

Ownership and provider verification

NPI-validated provider counts, state licensing cross-reference, entity structure, and ownership type - founder-owned, MSO-affiliated, PE-backed, or hospital-employed.

03

Revenue and EBITDA range estimates

Directional financial estimates built from provider-count benchmarks, adjusted for in-house procedures, imaging, specialty pharmacy, and other revenue layers specific to the sub-sector.

04

Competitive overlap mapping

Which PE-backed platforms are in the market, when they acquired, whether they are in buy-and-build mode or approaching an exit, and where the white space lies.

06

Deeply enriched practice profiles

For each priority target: sub-specialty mix, clinical footprint, website and public disclosure review, and relevant transaction history pulled from public filings and press.

07

Approach notes

Practical guidance on how to navigate past practice gatekeepers to the actual decision makers. Names where public, reception patterns, banker relationships, and how the target has responded to prior inbound.

08

Contact routing

Website, phone, and email or contact form for every target. Not a lead list - a working call sheet your team can operationalize on Day 1.

Methodology

Six to ten weeks of manual desk research, compressed to two to five business days.

The same market map most corp dev teams produce in six to ten weeks is produced in two to five business days by combining three layers:

  • Data extraction infrastructure that queries state licensing databases, NPI registries, CMS provider files, payer directories, and commercial data providers in parallel rather than serially.
  • A scoring framework calibrated to your buy-box or prospect criteria - specialty, geography, size thresholds, ownership preferences, payer mix signals - not a generic “is this attractive” filter.
  • Practitioner judgment on what AI cannot automate: which sixty-two-year-old founder is likely ready versus the forty-five-year-old still building, which MSO is an actual competitor versus an irrelevant one, which market has consolidation room versus being saturated.

This is not a data pull. It is a deal-team-ready deliverable, calibrated for investment committee review on Day 1 with no internal cleanup required.

Who It Fits

Built for deal teams on both sides of the transaction.

PE-backed healthcare platforms

Building out add-on pipelines in new MSAs or expanding into adjacent sub-specialties. Typical use: an investment committee greenlights a new vertical or geography, and you need a ready-for-partner universe within a week to start approach.

Private equity funds

Entering a new sub-sector thesis. Typical use: your investment committee is finalizing a thesis and needs market structure intelligence before committing to active sourcing or a full-time BD hire.

Investment banks

Two jobs. Winning new sell-side mandates by arriving at a physician owner call with intelligence no competing banker has - the ranked pitch list, the decision-maker identification, the market context. And building defensible buyer universes spanning strategics, PE-backed platforms, and financial sponsors, especially in sub-sectors you cover less actively.

Health systems

Evaluating partnership, JV, or acquisition opportunities in specific markets. Typical use: you are evaluating an MSA or a sub-specialty consolidation and need an independent market structure view.

Timeline

Two to five business days typical.

Most engagements deliver in that window. Complex scopes - multi-state, multi-sub-specialty, or sell-side buyer universes requiring international reach - may extend to seven to ten business days. The exact timeline is scoped during the discovery call.

Pricing

Fixed project fee.

Scoped by sub-sector complexity, geography, and engagement depth. Standard structure: 50% deposit to kick off work, 50% net 30 on delivery. Healthcare M&AI does not use success fees, contingency compensation, or transaction-based pricing - all engagements are advisory research.

Representative Work

Recent engagements.

Client names and deal identifiers withheld. Output paraphrased to preserve confidentiality.

PE-backed platform - buy-side
50+ independent physician groups identified, enriched, and tiered across a three-state Southeast footprint. Delivered in 4 business days.

A PE-backed platform building an add-on pipeline in a new sub-specialty had an investment committee deadline and no internal bandwidth to build the universe in parallel with two live processes. Delivered a ranked call list tiered by succession signal and approach priority, ownership verification on all Tier 1 targets, competitive overlap against four PE-backed operators already in market, and approach notes for the top ten prospects. The business development team initiated outreach the week of delivery.

Investment bank - sell-side mandate sourcing
48+ practices screened across four major metros. 13 independent prospects ranked by succession signal - four with physician-owners aged 60 or older.

A healthcare advisory firm expanding coverage into a new sub-sector needed intelligence on which independent practices to pitch for sell-side representation - not a buyer universe, which they already had. Delivered a tiered pitch list with decision-maker identification and estimated owner age for each target, directional revenue and EBITDA ranges paired with payer mix estimates, and approach notes calibrated to opening a sell-side conversation at the physician level - designed to route past the front desk and land in front of the decision-maker directly.

PE fund - thesis development
90+ practices screened across two adjacent states. 30+ independent targets verified, profiled, and ranked against a new sub-sector buy-box in 5 business days.

A PE fund finalizing a thesis entry in a new specialty vertical needed market structure intelligence before committing to active sourcing or a full-time BD hire. Delivered a tiered target universe with ownership verification, revenue and EBITDA range estimates, competitive landscape mapping of PE-backed operators already in market, and valuation benchmarking against recent comparable transactions in the sub-sector. The market map served as the foundation for the fund’s investment committee materials on the new vertical.

FAQ

Common questions about market maps.

How is a healthcare market map different from a PitchBook search or a lead list?

PitchBook, Grata, CapIQ, ZoomInfo, and Definitive Healthcare all get you to a universe of names - not a call sheet. They won’t tell you the physician owner is 63 with no succession plan, whether a junior partner recently left the group, or which 15 of 200 names are worth a call this month. A market map delivers the enrichment layer those platforms don’t: ownership verification, competitive overlap, succession signals, deeply enriched practice profiles, and approach notes built to route past the front desk to the actual decision maker.

What data sources does a healthcare market map use?

State licensing databases, CMS Provider of Services files, NPI registries, payer directories, commercial data providers where subscribed, SEC filings for public operators, county records for ownership verification, and professional association directories. Public information only unless otherwise agreed under a mutual NDA.

Can you build a market map for any healthcare sub-sector?

Yes. Core verticals with deepest practitioner experience include urgent care, oncology, post-acute, physician services (primary care, multi-specialty, specialty), ophthalmology, dental, and behavioral health. Adjacent verticals are scoped with additional intake during the discovery call.

Can you build a sell-side buyer universe rather than a buy-side target list?

Yes. Sell-side mandates are a common use case. The buyer universe includes strategic acquirers, PE-backed platforms with fit to the target, and financial sponsors with active theses in the sub-sector. Each buyer is evaluated for acquisition history, current capital availability, and thesis fit against the seller.

Start a market map engagement.

Tell us the sub-sector, the geography, and the side of the table. We’ll scope the engagement on a 25-minute discovery call and deliver the map within two to five business days.

Start a Project Book a 25-min call